Treatment of Urinary Tract Infections in Elderly Men

Diagnostic Considerations

The European Urology guidelines recommend verifying genuine UTI symptoms, such as fever, rigors, clear delirium, recent-onset dysuria, frequency, urgency, or costovertebral angle tenderness, before prescribing antibiotics in elderly men 4, 1
The American College of Physicians suggests that a positive urine culture alone without symptoms is considered asymptomatic bacteriuria and should not be treated, as it occurs in 15-50% of elderly men and can lead to harm when treated 1

Urine culture and susceptibility testing should be obtained before initiating antibiotics in elderly men, as UTI in males is considered complicated and requires culture-guided therapy 2, 3
The European Urology guidelines recommend using the Cockcroft-Gault equation to calculate creatinine clearance and guide antibiotic dosing, rather than relying on serum creatinine alone 3

The Infectious Diseases Society of America recommends trimethoprim-sulfamethoxazole, nitrofurantoin, or fosfomycin as first-line empiric antibiotics for elderly men with symptomatic UTI, with treatment duration of 7 days 2, 3
The American Geriatrics Society suggests that fluoroquinolones, such as levofloxacin or ciprofloxacin, can be used as alternative options, but require mandatory renal dose adjustment and should be avoided if local resistance rates are high or the patient has multiple comorbidities 2, 3

The American Urological Association recommends assessing for complicating factors, such as prostatic hyperplasia, urinary retention, or high post-void residual volume, which may require longer treatment or urological evaluation 2, 3
The National Institute on Aging suggests that medication interactions are critical in elderly patients, and that trimethoprim-sulfamethoxazole should be avoided with ACE inhibitors or ARBs due to hyperkalemia risk 2, 3

The Infectious Diseases Society of America provides Grade A-I evidence that treating asymptomatic bacteriuria in elderly men does not reduce morbidity or mortality and leads to increased antimicrobial resistance and adverse drug events 1